This project focuses on the pharmacology of brain serotonin (5-HT) neurons after chronic exposure to 5-HT uptake blockers. Impaired function of 5-HT1A receptors has been associated with neurological and psychiatric disorders. Chronic exposure to 5-HT uptake blockers reduces 5-HT1A receptor function of serotonergic cells in the midbrain. However, little information is currently available regarding the effect of 5-HT uptake blockers on hypothalamic post-synaptic 5-HT1A receptors. Moreover, no studies have investigated such fundamental issues as the time- course, dose-response relationship or duration of the effects of 5-HT uptake blockers on 5- HT1A receptor function. The applicant has recently found that the 5-HT uptake blocker fluoxetine (10 mg/kg/day, 21 days) reduces 5-HT1A receptor-mediated plasma ACTH and oxytocin responses in a time-dependent manner. A single injection of fluoxetine had no effect. The hypothesis is advanced that chronic exposure to 5-HT uptake blockers causes adaptational changes in serotonergic neurotransmission, resulting in reduced 5-HT1A receptor function in the hypothalamus. The proposed studies will characterize the changes in hypothalamic post-synaptic 5- HT1A receptors induced by chronic exposure to 5-HT uptake blockers. Biochemical approaches will focus on changes in 5-HT1A receptor density and their signal transduction mechanisms (coupling to G-proteins). In addition, the responsiveness of hypothalamic 5-HT1A receptors will be determined from the neuroendocrine responses to specific 5- HT1A agonists.
Specific Aim 1 will investigate the time-course of effects of 5-HT uptake blockers on hypothalamic 5-HT1A receptors, their signal transduction mechanisms, and endocrine responses to 5-HT1A agonists.
Specific Aim 2 will determine the dose-response effects of chronic exposure to 5-HT uptake blockers on 5-HT1A receptors, their signal transduction mechanisms, and hormone responses mediated by 5-HT1A receptors. So far, studies have used doses that are 10 fold higher than clinically relevant doses. This study will determine the minimal dose of fluoxetine that will reduce 5-HT1A receptor function. The final Specific Aim will determine the duration of altered 5- HT1A receptor function after withdrawal from 5-HT uptake blockers. A comparison of endocrine changes with biochemical indices of 5-HT1A receptor function may provide a model of withdrawal from 5-HT uptake blockers.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Program Officer
Edwards, Emmeline
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Loyola University Chicago
Schools of Medicine
United States
Zip Code
Grippo, Angela J (2009) Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models. Neurosci Biobehav Rev 33:171-80
Grippo, Angela J; Johnson, Alan Kim (2009) Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 12:1-21
Petrunich, Maureen L; Garcia, Francisca; Carrasco, Gonzalo A et al. (2008) Prolonged 5-HT1A/5-HT2A receptor cross-talk is absent prior to adulthood in rats. Neuroreport 19:1457-61
Crane, James W; Shimizu, Keiko; Carrasco, Gonzalo A et al. (2007) 5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: time dependence and regional differences. Brain Res 1183:51-9
Shi, Ju; Damjanoska, Katerina J; Singh, Rakesh K et al. (2007) Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors. J Pharmacol Exp Ther 323:248-56
Carrasco, Gonzalo A; Van de Kar, Louis D; Jia, Cuihong et al. (2007) Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo. J Pharmacol Exp Ther 320:1078-86
Carrasco, G A; Van de Kar, L D; Sullivan, N R et al. (2006) Cocaine-mediated supersensitivity of 5-HT2A receptors in hypothalamic paraventricular nucleus is a withdrawal-induced phenomenon. Neuroscience 143:7-13
Sullivan, Nicole R; Crane, James W; Damjanoska, Katerina J et al. (2005) Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo. Naunyn Schmiedebergs Arch Pharmacol 371:18-26
Landry, Michelle; Frasier, Mark; Chen, Zhuo et al. (2005) Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin. Synapse 58:102-9
Li, Qian; Holmes, Andrew; Ma, Li et al. (2004) Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. J Neurosci 24:10868-77

Showing the most recent 10 out of 40 publications